This study evaluated the prevalence of hepatitis C virus (HCV) infections in Korea. Pooled estimates of the anti-HCV positivity were calculated using the data published in 15 reports on the general population and health check-up examinees. The overall pooled estimate of the prevalence of HCV among middle-aged adults (40 yr old and above) was 1.68% (95% confidence interval: 1.51-1.86%) during the year of 1990-2000 among the general population. Most of the published data indicated that the prevalence of anti-HCV increased with age. The anti-HCV positivity was significantly higher in females than in males. Because the risk of HCV exposure in blood recipients has decreased remarkably, the spread of HCV through means other than a transfusion mus...
SummaryBackgroundTrends in hepatitis B virus (HBV) infection are important in evaluating the effecti...
Adult seroprevalence of HAV is decreasing in developed countries including South Korea, due to gener...
SummaryObjectiveEarly studies on blood donors point to a seroprevalence of approximately 0.25% for h...
The anti-hepatitis C virus (HCV) prevalence in South Korean adults is estimated to be 0.8%, suggesti...
Viral hepatitis is the most important cause of acute and chronic liver disease in Korea. Particularl...
Objective: Due to the various changes caused by the COVID-19 pandemic, some infectious diseases show...
Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis, hepatocellular carcinoma, and...
AbstractObjectivesThe purpose of this study was to investigate the seroprevalence of hepatitis A vir...
The epidemiologic shift of hepatitis A virus (HAV) infection in the South Korean population resulted...
Chronic hepatitis C infection is one of the main causes of chronic liver disease, cirrhosis and hepa...
Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute...
To assess the true prevalence of HCV and understand the epidemiological features of the infection in...
BACKGROUND/OBJECTIVE: It is generally recommended that patients with chronic viral hepatitis should ...
Korea is one of the endemic areas of hepatitis B virus infection. In clinical practice, we have sus...
From April 2008 to November 2008, many cases of hepatitis A were reported in Seoul and Gyeonggi Prov...
SummaryBackgroundTrends in hepatitis B virus (HBV) infection are important in evaluating the effecti...
Adult seroprevalence of HAV is decreasing in developed countries including South Korea, due to gener...
SummaryObjectiveEarly studies on blood donors point to a seroprevalence of approximately 0.25% for h...
The anti-hepatitis C virus (HCV) prevalence in South Korean adults is estimated to be 0.8%, suggesti...
Viral hepatitis is the most important cause of acute and chronic liver disease in Korea. Particularl...
Objective: Due to the various changes caused by the COVID-19 pandemic, some infectious diseases show...
Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis, hepatocellular carcinoma, and...
AbstractObjectivesThe purpose of this study was to investigate the seroprevalence of hepatitis A vir...
The epidemiologic shift of hepatitis A virus (HAV) infection in the South Korean population resulted...
Chronic hepatitis C infection is one of the main causes of chronic liver disease, cirrhosis and hepa...
Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute...
To assess the true prevalence of HCV and understand the epidemiological features of the infection in...
BACKGROUND/OBJECTIVE: It is generally recommended that patients with chronic viral hepatitis should ...
Korea is one of the endemic areas of hepatitis B virus infection. In clinical practice, we have sus...
From April 2008 to November 2008, many cases of hepatitis A were reported in Seoul and Gyeonggi Prov...
SummaryBackgroundTrends in hepatitis B virus (HBV) infection are important in evaluating the effecti...
Adult seroprevalence of HAV is decreasing in developed countries including South Korea, due to gener...
SummaryObjectiveEarly studies on blood donors point to a seroprevalence of approximately 0.25% for h...